Mirae Asset Global Investments’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$152K	Buy	6,470 +518	+9%	+$13.2K	﹤0.01%	1113
2025 Q4	$173K	Buy	5,952 +1,316	+28%	+$33.7K	﹤0.01%	1163
2025 Q3	$87.4K	Buy	4,636 +31	+0.7%	+$489	﹤0.01%	1242
2025 Q2	$64.6K	Buy	4,605 +595	+15%	+$8.34K	﹤0.01%	1223
2025 Q1	$63.1K	Buy	4,010 +110	+3%	+$1.55K	﹤0.01%	1199
2024 Q4	$55.8K	Sell	3,900 -328	-8%	-$3.59K	﹤0.01%	1254
2024 Q3	$39.6K	Buy	4,228 +772	+22%	+$7.62K	﹤0.01%	1340
2024 Q2	$32.6K	Sell	3,456 -43,198	-93%	-$391K	﹤0.01%	1318
2024 Q1	$469K	Buy	+46,654	New	+$348K	﹤0.01%	1932
2023 Q4	–	Sell	-38,023	Closed	-$202K	–	2529
2023 Q3	$202K	Buy	38,023 +606	+2%	+$5.15K	﹤0.01%	2292
2023 Q2	$336K	Buy	37,417 +5,435	+17%	+$60.3K	﹤0.01%	2130
2023 Q1	$352K	Buy	31,982 +11,509	+56%	+$166K	﹤0.01%	2090
2022 Q4	$303K	Buy	20,473 +4,361	+27%	+$76.2K	﹤0.01%	2156
2022 Q3	$308K	Buy	+16,112	New	+$365K	﹤0.01%	2143